Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIONTECH | 8 | 13 | +0,18 % | ||
| AC IMMUNE | 7 | - | +7,76 % | ||
| KYMERA THERAPEUTICS | 6 | 6 | -1,28 % | ||
| MODERNA | 4 | 16 | +0,91 % | ||
| ALNYLAM PHARMACEUTICALS | 4 | 9 | -0,17 % | ||
| AVADEL PHARMACEUTICALS | 4 | 6 | 0,00 % | ||
| IMMUNOVANT | 4 | 1 | +13,54 % | ||
| RHYTHM PHARMACEUTICALS | 3 | 3 | +16,20 % | ||
| ROIVANT SCIENCES | 3 | 3 | +0,78 % | ||
| ENLIVEN THERAPEUTICS | 3 | 2 | -6,78 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17:57 | BioNTech startet durch: 62?% Kurspotenzial winken | 27 | börsennews.de | BioNTech sorgt mit positiven Phase-3-Daten zum Antikörper Gotistobart für Aufsehen in der Krebsforschung. Analysten sehen hohes Kurspotenzial, insbesondere durch die Pipeline-Innovationen in der Onkologie... ► Artikel lesen | |
| 17:30 | TD Cowen raises Royalty Pharma stock price target on growth outlook | 1 | Investing.com | ||
| 17:26 | Crinetics Pharmaceuticals (CRNX) Poised for Transformational Growth in 2026: Piper Sandler | 2 | Insider Monkey | ||
| 17:10 | Amgen obesity marketing leader Chris Boulton takes reins at metabolic biotech Prolynx | 4 | FiercePharma | ||
| 17:00 | Credo Technology, Micron, Berkshire Hathaway, Netflix u.a. - Calling USA | BNP Paribas | |||
| 16:50 | REGENERON PHARMACEUTICALS INC zündet Kursrakete! | 2 | Maximilian Berger | ||
| 16:46 | Sarepta Therapeutics: Aktie fällt nach Ankündigung von Anleihentausch | 4 | Investing.com Deutsch | ||
| 16:30 | Citadel Group discloses 1.24% stake in Avadel Pharmaceuticals | 1 | Investing.com | ||
| 16:30 | EILMELDUNG: Biontech-Aktie im Fokus - wann platzt endlich der Knoten? | Hebelschein-Spekulant | |||
| 16:10 | CRMD Up More Than 40% YTD: Time to Buy, Sell or Hold the Stock? | 1 | Zacks | ||
| 16:06 | Steven Lefkowitz Implements A Sell Strategy: Offloads $475K In Cormedix Stock | 1 | Benzinga.com | ||
| 16:00 | Geron To Reduce One-Third Of Current Workforce As Part Of Restructuring Plan | 6 | RTTNews | ||
| 16:00 | Kymera gains Fast Track status for oral candidate KT-621 for eczema | 2 | Seeking Alpha | ||
| 15:34 | Illumina investiert in MyOme zur Weiterentwicklung KI-gestützter Genom-Gesundheitsmodelle | 3 | Investing.com Deutsch | ||
| 15:34 | WVE Stock Surges More Than 180% in a Week: What Is Driving This Rally? | 12 | Zacks | ||
| 15:30 | Enliven Therapeutics appoints Rick Fair as new CEO | 1 | Investing.com | ||
| 15:18 | Geron to lay off a third of workforce under restructuring program | 2 | Seeking Alpha | ||
| 15:15 | MyOme, Inc: Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually | 141 | PR Newswire | Partnership unites Illumina's leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for early detection and prevention. SAN DIEGO... ► Artikel lesen | |
| 15:00 | Centessa Pharmaceuticals CEO Saurabh Saha To Step Down; Mario Accardi Named Replacement | 1 | RTTNews | ||
| 15:00 | Enliven Therapeutics, Inc.: Enliven Therapeutics Announces New CEO to Drive Next Phase of Development | 62 | PR Newswire | Rick Fair, a seasoned executive with deep experience developing and commercializing hematology products, joins Enliven as Chief Executive Officer
Co-Founder Sam... ► Artikel lesen |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .